152 Episodes
10 Ratings
2019 First episode
23K YouTube views About Vital Health Podcast Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.
Publisher Vital Health Podcast
Category science
Language en
Explicit No
First episode 12 Feb 2019
Latest episode 9 Jul 2026 Latest episodes 152 episodes in the feed.
9 Jul 2026
Michael Penn: What The IRA Means For Oncology Innovation In this episode of the Vital Health Podcast, host Duane Schulthess (https://www.linkedin.com/in/duane-schulthess-66ba39b7/) speaks with Michael Penn (https://www.linkedin.com/in/michael-d-penn/), US Head of Reimbursement and Public Policy at Sanofi (https://www.linkedin.com/company/sanofi/), to discuss how pricing policy, the Inflation Reduction Act (IRA), small-molecule incentives, orphan drug provisions, and Most Favored Nation (MFN) proposals could shape oncology innovation, patient access, and U.S. biopharmaceutical competitiveness.
Key Topics:
IRA and Oncology: Late-stage research shifts, follow-on studies, lead asset selection.
Small-Molecule Incentives: Pill penalty concerns, portfolio reassessment, biologic comparisons.
Orphan Drug Policy: Orphan Cures Act provisions, rare disease investment, post-market indication development.
Patient Access Risks: Fewer treatment options, affordability questions, unmet needs in oncology.
U.S. Competitiveness: MFN proposals, global R&D incentives, comparisons with China and Europe.
Our new preprint on the IRA’s impact on late-stage R&D is available on our website (https://vitaltransformation.com/2026/05/preprint-new-research-the-inflation-reduction-acts-impact-upon-late-stage-rd/) and examines declines in small-molecule oncology research and orphan oncology studies.
Opinions expressed are those of the speakers. Recorded at ASCO 2026 on 5/31/26. The Vital Health Podcast is a production of Vital Transformation LLC © 2026.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
2 Jul 2026
MSD Early Bird Podcast: Changing Demographics and the Case for Renewed Investment in Health Across Europe and around the world, demographic change is reshaping our societies. Longer life expectancy, aging populations, and evolving workforce dynamics are creating both new opportunities and growing pressure on healthcare systems, economies, and public policy.
Against this backdrop, health and innovation play an increasingly important role in building resilient societies and supporting healthier, more productive lives. Investing in prevention, early intervention, innovative healthcare solutions, and forward-looking health policies is becoming essential to meeting these challenges.
In this Early Bird edition of the Vital Health Podcast, Duane Schulthess (https://www.linkedin.com/in/duane-schulthess-66ba39b7/) sits with Mike Hodin (linkedin.com/in/hodin) (Global Coalition on Aging - GCOA (https://www.linkedin.com/company/global-coalition-on-aging/); CEO) and Francesca Colombo (https://www.linkedin.com/in/francesca-colombo-a662a51/) (Organisation for Economic Co-operation and Development - OECD (linkedin.com/company/organisation-eco-cooperation-development-organisation-cooperation-developpement-eco); Head, Health Division) to explore how strategic investment in health and innovation can help address demographic change and contribute to sustainable social and economic outcomes. They highlight the value of prevention, including adult vaccination, the importance of cardiovascular health, and the critical role of early detection, diagnosis, and timely treatment in cancer care.
Opinions expressed are those of the speakers. Recorded on 6/17/26. This podcast was made with the support of Merck Sharp & Dohme (https://www.linkedin.com/company/msd-global). The Vital Health Podcast is a production of Vital Transformation LLC (https://www.linkedin.com/company/vital-transformation/) © 2026.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
25 Jun 2026
Bill Smith: How 340B Became A Hospital Profit Center In this episode of the Vital Health Podcast, host Duane Schulthess (https://www.linkedin.com/in/duane-schulthess-66ba39b7/) speaks with Bill Smith (https://www.linkedin.com/in/william-smith-phd-54628b18/) (Senior Fellow and Director, Life Sciences Initiative at The Pioneer Institute (https://www.linkedin.com/company/pioneer-institute-for-public-policy-research/)) to discuss how the 340B program has evolved from a safety net drug discount program into a major source of hospital revenue, what new research suggests about charity care and Medicaid access, and why transparency, hospital consolidation, and broader drug pricing policy are reshaping incentives across oncology and biopharma.
Key Topics:
340B Origins: Medicaid best price, safety net intent, clinic and hospital eligibility.
Hospital Arbitrage: Buy-low sell-high incentives, affluent satellite sites, oncology drug spreads.
Charity Care: Lower reported charity care, Medicaid access concerns, variation across hospital systems.
Transparency Reforms: State reporting laws, separate audited accounts, minimum charity care requirements.
Policy Collisions: Inflation Reduction Act (IRA) price controls, Most-Favored-Nation (MFN) pressure, oncology consolidation, biopharma investment risks.
Opinions expressed are those of the speakers. Recorded 6/5/26. The Vital Health Podcast is a production of Vital Transformation LLC © 2026.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
Who has been a guest on Vital Health Podcast Names identified in recent episode analyses. Showing up to five guests.
Ipsita Smolinski Steve Potts Robert Coughlin Jocelyn Ulrich Jenni Nordborg Reach and audience Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views 23,421 Score snapshot 15 Sept 2025
Apple Podcasts (US) 4.3 / 5 9 ratings
Spotify 5.0 / 5 1 ratings Podcast Authority Score: 51 / 100 A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology .
Shows with a similar audience Research this show Explore Pod Engine's podcast research tools and transcript access.
See plans Is this your podcast? Claim your show to manage its details on Pod Engine.
Claim Vital Health Podcast Where this data comes from Each source has its own observation date. These dates do not mean all data was checked at once.
RSS feed Last successful check: 16 Sept 2026 .
Apple Podcasts ratings (US) Snapshot recorded: 19 Oct 2026 .
Spotify ratings Snapshot recorded: 18 Oct 2026 . Host of Vital Health Podcast? Claim your podcast to manage its listing and keep your show details accurate.
Claim this podcast Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice .
Explore this showPodcast research with Pod Engine
See plans 
